Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Dimitriou

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Journal of Pediatric Hematology/Oncology|April 9, 2008
Biologic characteristics of mesenchymal stromal cells and their clinical applications in pediatric patientsIordanis Pelagiadis, Helen Dimitriou, Maria Kalmanti
Immunological Investigations|September 6, 2013
Could mesenchymal stromal cells have a role in childhood autoimmune diseases?Margarita Pesmatzoglou, Helen Dimitriou, Eftichia Stiakaki
Pediatrics International : Official Journal of the Japan Pediatric Society|May 2, 2002
Management of childhood diseases in the Byzantine period: II - exanthematic diseasesIoanna A Ramoutsaki, Helen Dimitriou, Maria Kalmanti
Pediatrics International : Official Journal of the Japan Pediatric Society|September 13, 2002
Management of childhood diseases during the Byzantine period: VI - ocular diseasesIoanna A Ramoutsaki, Helen Dimitriou, Maria Kalmanti
Tissue Engineering. Part B, Reviews|May 6, 2008
Stem cells: promises versus limitationsDespoina M Choumerianou, Helen Dimitriou, Maria Kalmanti
Pediatrics International : Official Journal of the Japan Pediatric Society|May 2, 2002
Management of childhood diseases in the Byzantine period: I -- analgesiaIoanna A Ramoutsaki, Helen Dimitriou, Maria Kalmanti
Pediatrics International : Official Journal of the Japan Pediatric Society|September 13, 2002
Management of childhood diseases in the Byzantine period: VII - epilepsyIoanna A Ramoutsaki, Helen Dimitriou, Maria Kalmanti
Cytotherapy|March 15, 2012
CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord bloodIordanis Pelagiadis, Konstantinos Relakis, Lida Kalmanti, et al.
Pediatric Hematology and Oncology|May 27, 2004
Amifostine as differentiating agent in cord blood and bone marrow cultures from children with hematological disordersVassiliki Danilatou, Helen Dimitriou, Eftichia Stiakaki, et al.
BMC Pediatrics|March 5, 2013
CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in childrenDiana-Michaela Fitrolaki, Helen Dimitriou, Maria Kalmanti, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Journal of Pediatric Hematology/Oncology|April 9, 2008
Biologic characteristics of mesenchymal stromal cells and their clinical applications in pediatric patientsIordanis Pelagiadis, Helen Dimitriou, Maria Kalmanti
Immunological Investigations|September 6, 2013
Could mesenchymal stromal cells have a role in childhood autoimmune diseases?Margarita Pesmatzoglou, Helen Dimitriou, Eftichia Stiakaki
Pediatrics International : Official Journal of the Japan Pediatric Society|May 2, 2002
Management of childhood diseases in the Byzantine period: II - exanthematic diseasesIoanna A Ramoutsaki, Helen Dimitriou, Maria Kalmanti
Pediatrics International : Official Journal of the Japan Pediatric Society|September 13, 2002
Management of childhood diseases during the Byzantine period: VI - ocular diseasesIoanna A Ramoutsaki, Helen Dimitriou, Maria Kalmanti
Tissue Engineering. Part B, Reviews|May 6, 2008
Stem cells: promises versus limitationsDespoina M Choumerianou, Helen Dimitriou, Maria Kalmanti
Pediatrics International : Official Journal of the Japan Pediatric Society|May 2, 2002
Management of childhood diseases in the Byzantine period: I -- analgesiaIoanna A Ramoutsaki, Helen Dimitriou, Maria Kalmanti
Pediatrics International : Official Journal of the Japan Pediatric Society|September 13, 2002
Management of childhood diseases in the Byzantine period: VII - epilepsyIoanna A Ramoutsaki, Helen Dimitriou, Maria Kalmanti
Cytotherapy|March 15, 2012
CD133 immunomagnetic separation: effectiveness of the method for CD133(+) isolation from umbilical cord bloodIordanis Pelagiadis, Konstantinos Relakis, Lida Kalmanti, et al.
Pediatric Hematology and Oncology|May 27, 2004
Amifostine as differentiating agent in cord blood and bone marrow cultures from children with hematological disordersVassiliki Danilatou, Helen Dimitriou, Eftichia Stiakaki, et al.
BMC Pediatrics|March 5, 2013
CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in childrenDiana-Michaela Fitrolaki, Helen Dimitriou, Maria Kalmanti, et al.
Pageof 5